title: In vitro effects of human recombinant alpha-2b interferon on Ph1+ chronic myelogenous leukemia cells maintained in long term marrow cultures: a functional and morphological analysis.
abstract: In this study in vitro results obtained with hu rec IFN-alpha 2b on Ph1+ stem cells from patients with chronic myelogenous leukemia in chronic phase (CML in CP) will be discussed: cells were incubated with different IFN concentrations (100, 1000, 10000 IU/ml) for different times (24, 96 hrs, 8, 15, days) and maintained in long term marrow cultures (LTMC); CFU-GM assay, cytochemistry and cytogenetic analyses were performed weekly. A high sensitivity of CML cells to the in vitro treatment with IFN was observed. Cell count in LTMC showed a progressive reduction inversely proportional to time of incubation and concentration of IFN; a marked decrease in colony growth was observed at the end of incubations and during the course of LTMC. Low concentrations of IFN permitted a morphological maturation and the expression of alkaline phosphatase. Cytogenetic analyses showed a marked reduction of mytoses in cultures treated with high concentrations of IFN as result of a combined cytostatic and cytolitic effect; the persistance of 100% Ph1+ cells in LTMC and in CFU-GM colonies might be related, as opposed to in vivo results, to different IFN exposure conditions or might be influenced by other factors.
authors.affiliation: Department of Biopathology, University La Sapienza, Rome, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Sandrelli
authors.forename: P
authors.initials: P
authors.lastname: De Fabritiis
authors.forename: A
authors.initials: A
authors.lastname: Cafolla
authors.forename: M
authors.initials: M
authors.lastname: Nanni
authors.forename: F
authors.initials: F
authors.lastname: Simone
authors.forename: L
authors.initials: L
authors.lastname: De Felice
authors.forename: G D
authors.initials: GD
authors.lastname: Di Nucci
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
mesh_terms: D001854:Bone Marrow Cells; D002478:Cells, Cultured; D003582:Cytogenetics; D006651:Histocytochemistry; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology*; D014411:Neoplastic Stem Cells / Q000473:pathology; D011994:Recombinant Proteins; D013234:Stem Cells; D014407:Tumor Cells, Cultured
chemical_list: D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins